Alexandre V Hirayama

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Blood advances

Blood

HemaSphere

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Fred Hutchinson Cancer Research Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fred Hutchinson Cancer Research Center Jun 25 2017

United States

Postdoctoral Research Fellow :: Clinical Research Division

Publications

Alexandre V Hirayama, Jocelyn H Wright, Kimberly S Smythe, Salvatore Fiorenza, Akira N Shaw, Jordan Gauthier, David G Maloney, Kikkeri N Naresh, Cecilia C S Yeung, Cameron J Turtle
PD-L1 + macrophage and tumor cell abundance and proximity to T cells in the pretreatment large B-cell lymphoma microenvironment impact CD19 CAR-T cell immunotherapy efficacy. HemaSphere 8 (8) (2024)
Alexandre V Hirayama, Jocelyn H Wright, Kimberly S Smythe, Salvatore Fiorenza, Akira N Shaw, Jordan Gauthier, David G Maloney, Kikkeri N Naresh, Cecilia C S Yeung, Cameron J Turtle
PD-L1 + macrophage and tumor cell abundance and proximity to T cells in the pretreatment large B-cell lymphoma microenvironment impact CD19 CAR-T cell immunotherapy efficacy. HemaSphere 8 (8) (2024)
Alexandre V Hirayama, Marie Bleakley
CD19 occupancy may drive CARs further. Blood 143 (3) (2024)
Rahul Banerjee, Christina Poh, Alexandre V Hirayama, Jordan Gauthier, Ryan D Cassaday, Mazyar Shadman, Andrew J Cowan, Brian G Till, Damian J Green, Hans-Peter Kiem, Ajay K Gopal, David G Maloney
Answering the "Doctor, can CAR-T therapy cause cancer?" question in clinic. Blood advances 8 (4) (2024)
Rahul Banerjee, Christina Poh, Alexandre V Hirayama, Jordan Gauthier, Ryan D Cassaday, Mazyar Shadman, Andrew J Cowan, Brian G Till, Damian J Green, Hans-Peter Kiem, Ajay K Gopal, David G Maloney
Answering the "Doctor, can CAR-T therapy cause cancer?" question in clinic. Blood advances 8 (4) (2024)
Rahul Banerjee, Christina Poh, Alexandre V Hirayama, Jordan Gauthier, Ryan D Cassaday, Mazyar Shadman, Andrew J Cowan, Brian G Till, Damian J Green, Hans-Peter Kiem, Ajay K Gopal, David G Maloney
Answering the "Doctor, can CAR-T therapy cause cancer?" question in clinic. Blood advances (2024)
Alexandre V Hirayama, Marie Bleakley
CD19 occupancy may drive CARs further. Blood 143 (3) (2024)
Michael L Wang, Tanya Siddiqi, Leo I Gordon, Manali Kamdar, Matthew Lunning, Alexandre V Hirayama, Jeremy S Abramson, Jon Arnason, Nilanjan Ghosh, Amitkumar Mehta, Charalambos Andreadis, Scott R Solomon, Ana Kostic, Christine Dehner, Ricardo Espinola, Lily Peng, Ken Ogasawara, Amy Chattin, Laurie Eliason, Maria Lia Palomba
Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma (MCL): Primary Analysis of the MCL Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Cecilia C S Yeung, David W Woolston, Qian Vicky Wu, Jenna M Voutsinas, Ryan S Basom, Chris Davis, Alexandre V Hirayama, Kikkeri N Naresh
Abnormal bone marrow findings in patients following treatment with chimeric antigen receptor-T cell therapy. European journal of haematology (2023)
Emily C Liang, Aya Albittar, Jennifer J Huang, Alexandre V Hirayama, Erik L Kimble, Andrew J Portuguese, Aude G Chapuis, Mazyar Shadman, Brian G Till, Ryan D Cassaday, Filippo Milano, Hans-Peter Kiem, Stanley R Riddell, Cameron J Turtle, David G Maloney, Jordan Gauthier
Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL. Blood advances (2023)
Alexandre V Hirayama, Erik L Kimble, Jocelyn H Wright, Salvatore Fiorenza, Jordan Gauthier, Jenna M Voutsinas, Qian Vicky Wu, Cecilia C S Yeung, Nicolas Gazeau, Barbara S Pender, Delaney R Kirchmeier, Aiko Torkelson, Abigail Chutnik, Ryan D Cassaday, Aude G Chapuis, Damian J Green, Hans-Peter Kiem, Filippo Milano, Mazyar Shadman, Brian G Till, Stanley R Riddell, David G Maloney, Cameron J Turtle
Timing of Anti-PD-L1 Antibody Initiation Affects Efficacy/Toxicity of CD19 CAR-T Cell Therapy for Large B-Cell Lymphoma. Blood advances (2023)
Alexandre V Hirayama, Cassie K Chou, Takahiro Miyazaki, Rachel N Steinmetz, Henna A Di, Simon P Fraessle, Jordan Gauthier, Salvatore Fiorenza, Reed M Hawkins, Willem W Overwijk, Stanley R Riddell, A Mario Q Marcondes, Cameron J Turtle
A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR-T cell immunotherapy. Blood advances (2022)
Jordan Gauthier, Nicolas Gazeau, Alexandre V Hirayama, Joshua A Hill, Vicky Wu, Aisling Cearley, Paula Perkins, Angela Kirk, Mazyar Shadman, Victor A Chow, Ajay K Gopal, Alexandria Hodges Dwinal, Staci Williamson, Jessie Myers, Andy Chen, Sarah Nagle, Brandon Hayes-Lattin, Levanto Schachter, David G Maloney, Cameron J Turtle, Mohamed Lotfy Sorror, Richard T Maziarz
Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL. Blood 139 (26) (2022)
Andrew Jay Portuguese, Jordan Gauthier, Scott S Tykodi, Evan T Hall, Alexandre V Hirayama, Cecilia C S Yeung, Christopher D Blosser
CD19 CAR-T therapy in solid organ transplant recipients: case report and systematic review. Bone marrow transplantation (2022)
Krishna R Juluri, Vicky Wu, Jenna M Voutsinas, Jue Hou, Alexandre V Hirayama, Erin Mullane, Nancy Miles, David G Maloney, Cameron J Turtle, Merav Bar, Jordan Gauthier
Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy. Blood advances (2021)
Alexandre V Hirayama, Jordan Gauthier, Kevin Anthony Hay, Jenna M Voutsinas, Qian Wu, Ted Gooley, Daniel Li, Sindhu Cherian, Xueyan Chen, Barbara S Pender, Reed M Hawkins, Aesha Vakil, Rachel N Steinmetz, Utkarsh H Acharya, Ryan D Cassaday, Aude G Chapuis, Tejaswini M Dhawale, Paul C Hendrie, Hans-Peter Kiem, Ryan C Lynch, Jorge Ramos, Mazyar Shadman, Brian G Till, Stanley R Riddell, David G Maloney, Cameron J Turtle
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells. Blood 133 (17) (2019)
Kevin Anthony Hay, Jordan Gauthier, Alexandre V Hirayama, Jenna M Voutsinas, Qian Vicky Wu, Daniel Li, Theodore A Gooley, Sindhu Cherian, Xueyan Chen, Barbara S Pender, Reed M Hawkins, Aesha Vakil, Rachel N Steinmetz, Gary Schoch, Aude G Chapuis, Brian G Till, Hans-Peter Kiem, Jorge D Ramos, Mazyar Shadman, Ryan D Cassaday, Utkarsh H Acharya, Stanley R Riddell, David G Maloney, Cameron J Turtle
Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy. Blood 133 (15) (2019)

Alexandre V Hirayama.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alexandre V Hirayama